18280074. COMBINATORY THERAPY FOR PREVENTING, INHIBITING, TREATING, OR REDUCING ANEURYSMS simplified abstract (The Regents of the University of California)
Contents
- 1 COMBINATORY THERAPY FOR PREVENTING, INHIBITING, TREATING, OR REDUCING ANEURYSMS
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 COMBINATORY THERAPY FOR PREVENTING, INHIBITING, TREATING, OR REDUCING ANEURYSMS - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 What is the specific mechanism of action by which the folate compound and calcium channel blocker combination treats aneurysms?
- 1.11 Are there any potential side effects or contraindications associated with the use of these pharmaceutical compositions for aneurysm treatment?
- 1.12 Original Abstract Submitted
COMBINATORY THERAPY FOR PREVENTING, INHIBITING, TREATING, OR REDUCING ANEURYSMS
Organization Name
The Regents of the University of California
Inventor(s)
Hua Cai of Los Angeles CA (US)
COMBINATORY THERAPY FOR PREVENTING, INHIBITING, TREATING, OR REDUCING ANEURYSMS - A simplified explanation of the abstract
This abstract first appeared for US patent application 18280074 titled 'COMBINATORY THERAPY FOR PREVENTING, INHIBITING, TREATING, OR REDUCING ANEURYSMS
Simplified Explanation
The present disclosure relates to pharmaceutical compositions comprising a folate compound and a calcium channel blocker, as well as the method for using such pharmaceutical compositions in the treatment of aneurysms.
- Folate compound and calcium channel blocker combined in pharmaceutical compositions for treating aneurysms.
- Method for using the pharmaceutical compositions in the treatment of aneurysms.
Potential Applications
The technology could be applied in the medical field for the treatment of aneurysms, providing a new approach to managing this condition.
Problems Solved
This innovation addresses the need for more effective treatments for aneurysms, potentially offering improved outcomes for patients with this condition.
Benefits
The combination of a folate compound and a calcium channel blocker in pharmaceutical compositions could lead to better therapeutic results for aneurysm patients, potentially reducing the risk of complications associated with this condition.
Potential Commercial Applications
The technology could have commercial applications in the pharmaceutical industry for the development of new treatments for aneurysms, catering to the growing demand for innovative therapies in this area.
Possible Prior Art
Prior art may include existing pharmaceutical compositions for the treatment of aneurysms, as well as research on the individual effects of folate compounds and calcium channel blockers on vascular health.
Unanswered Questions
What is the specific mechanism of action by which the folate compound and calcium channel blocker combination treats aneurysms?
The article does not delve into the detailed mechanism of action of the pharmaceutical compositions in treating aneurysms. Further research may be needed to elucidate this aspect.
Are there any potential side effects or contraindications associated with the use of these pharmaceutical compositions for aneurysm treatment?
The potential side effects or contraindications of the folate compound and calcium channel blocker combination in treating aneurysms are not discussed in the article. Additional studies may be necessary to assess the safety profile of this treatment approach.
Original Abstract Submitted
The present disclosure relates to pharmaceutical compositions comprising a folate compound and a calcium channel blocker, as well as the method for using such pharmaceutical compositions in the treatment of aneurysms.
